Key Highlights
- Lila Sciences aims to build the world’s first scientific superintelligence platform with fully autonomous labs.
- $200M in seed funding secured from Flagship Pioneering and leading investors, including General Catalyst and Abu Dhabi Investment Authority.
- AI-driven breakthroughs include novel antibodies, next-gen genetic medicine constructs, and sustainable materials for green energy and carbon capture.
- Led by renowned AI and scientific experts, including George Church, Ph.D., as Chief Scientist.
- Platform open to industry partners to accelerate discoveries in human health and sustainability.
Source: PR Newswire
Notable Quotes
- “Lila’s mission to responsibly achieve Scientific Superintelligence is born out of the belief that this is the most important opportunity of our time.” — Geoffrey von Maltzahn, Ph.D., Co-Founder & CEO at Lila Sciences
- “Lila represents an ambitious undertaking that we believe will accelerate science with enormous benefit to society.” — Noubar Afeyan, Ph.D., Founder & CEO at Flagship Pioneering
- “The next frontier in scientific discovery will come from enabling AI to design and run experiments at unprecedented scale.” — Molly Gibson, Ph.D., Co-Founder & President, Future Science at Lila Sciences
Why This Matters
Lila Sciences is reshaping the future of scientific discovery by integrating AI, automation, and robotics to scale experimentation and accelerate breakthroughs in healthcare, sustainability, and materials science. This unprecedented approach has the potential to redefine R&D, unlocking discoveries faster and more efficiently than ever before. With a $200M investment, Lila is well-positioned to lead the charge in scientific superintelligence, offering global impact across industries.
